New Orleans is one of the country’s most culturally, architecturally, and musically interesting cities. It will serve as the picturesque backdrop for Team Challenge, the Crohn’s & Colitis Foundation of America’s (CCFA) endurance training and fundraising program, to take over the city on February 28, 2016 for the Rock ‘n’ Roll New Orleans Marathon, Half Marathon & 10k.
For the first time ever, Team Challenge is recruiting for participants to run through the Big Easy while raising critical funds and awareness of Crohn’s disease and ulcerative colitis. Collectively known as inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis are painful, medically incurable diseases that attack the digestive system. There are more than 1.6 million Americans living with these chronic, debilitating diseases.
“Team Challenge provides people with an opportunity to raise critical research dollars while training to do something that, for many people, they never imagined they’d be able to do,” said Craig Comins, vice president of Team Challenge. “It is inspiring to see a group of people come together, some who have these diseases and some who do not, united in the mission of finding a cure for Crohn’s disease and ulcerative colitis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7512652-ccfa-team-challenge-recruit-nola/
Piano legend Byron Janis releases Byron Janis Live on Tour, an album of never before released live recordings of performances by the internationally celebrated pianist. It is Maestro Janis’ first release of new material in twenty years and celebrates the 70th anniversary of his very first RCA LP recording in 1947 at the age of 19 titled Bach/Liszt, Chopin. Byron Janis Live on Tour is an exclusive compilation of twelve works composed by Haydn, Chopin & Liszt. Also featured are two pieces composed for stage and screen by Janis himself, a “hot” collaboration on two pianos with Cy Coleman and, finally, a song he composed, “David’s Star,” for which his son Stefan wrote the lyrics. This album is dedicated to him, who died tragically of a heart attack in February of this year. The album is due to be released by Janis Eleven Enterprises, LTD on May 23 in honor of his 89th birthday which was celebrated on March 24, 2017. Each Volume will have a limited edition pressed vinyl release.
This release is the first of a three CD release musical journey. In the fall, Maestro Janis will release “Live from Leningrad,” a recording made in the early sixties in Russia. This was recorded unbeknownst to him while he was serving as a US Cultural Ambassador to the Soviet Union and surreptitiously presented to him nearly sixty years later. Then, just in time for the holidays, Byron Janis Live on Tour, Volume II will be available. Similar in format to Volume I, it will include a compilation of live recordings of performances of Mr. Janis from all over the world.
To view the multimedia release go to:
https://www.multivu.com/players/English/8108051-byron-janis-live-on-tour-volume-one/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Rare examples of classic cars can attract enormous interest from buyers, regularly breaking sales price records. Lauritz Lauritzen is the owner of one such car, Mercedes-Benz, cabriolet type B, model 320 from 1938 is the only one in the world produced at Mannheim Mercedes-Benz. Lauritz is excited about what price the car might fetch when it goes under the hammer in Denmark on June 26. The Mercedes represents the pinnacle of the German marque and only thirty-four cars were ever built.
This 1938c car is even more special as it is a top of the range ”Mannheim”-car further equipped with everything Mercedes could think of. In its time, it was probably one of the world's best cars. Today it presents itself accordingly - but only because the enthusiastic owner has put thousands of hours into it. Lauritz Lauritzen found the car in a barn in 1980 as a complete wreck, and the skilled Mercedes mechanic took on the challenge of restoring it to its former glory. Eleven years later the car was running again.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7861151-mercedes-resurrected-after-bomb-attack/
Losing weight and being healthier are at the top of everyone’s New Year’s resolutions. But, despite the best intentions, work, kids, and social events often push lifestyle changes to the bottom of the list. While many are familiar with type 2 diabetes, fewer are aware of prediabetes, a serious health condition that affects 86 million Americans (more than 1 in 3) and often leads to type 2 diabetes. People with prediabetes have higher than normal blood glucose (sugar) levels, but not high enough yet to be diagnosed with type 2 diabetes.
To raise awareness and help people with prediabetes know where they stand and how to prevent type 2 diabetes, the American Diabetes Association (ADA), the American Medical Association (AMA), and the Centers for Disease Control and Prevention (CDC) have partnered with the Ad Council to launch the first national public service advertising (PSA) campaign about prediabetes. The PSA campaign, featuring first-of-its-kind communications techniques, was developed pro bono by Ogilvy & Mather New York for the Ad Council.
Nearly 90 percent of people with prediabetes don’t know they have it and aren’t aware of the long-term risks to their health, including type 2 diabetes, heart attack, and stroke. Current trends suggest that, if not treated, 15 to 30 percent of people with prediabetes will develop type 2 diabetes within five years. The good news is that prediabetes often can be reversed through weight loss, diet changes and increased physical activity. Diagnosis is key: research shows that once people are aware of their condition, they are much more likely to make the necessary lifestyle changes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7731551-ad-council-prediabetes-psa/
Death Be Not Proud is the thrilling second installment in The Secret of the Journal series. Professor Emma D’Eresby flees her teaching position in Maine after a vicious attack by a psychotic colleague, but mysterious secrets and suspense still follow her back to her hometown in England. Learn more about this book here, http://bit.ly/1aLIAPr Romantic Thriller
The Ferraro family is under attack and one of them will die.
When a mysterious woman applies to be Ricco Ferraro’s Shibari rope model realizes she’s a shadow rider, just as he is. Their attraction becomes passion and passion becomes dangerous as the he discovers she’s an assassin sent to kill him.
Now Ricco must decide if she’s the threat, or if those who sent her are. Mystery, passion, drama and paranormal mix to bring us the Shadow Reaper. Find out more at http://www.ChristineFeehan.com
https://twitter.com/AuthorCFeehan
https://www.instagram.com/authorcfeehan/
http://www.christinefeehan.com/community/login.php Genre- Paranormal romance, thriller
A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma.
The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor.
To view the multimedia release go to:
https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
https://youtu.be/CsF6J4JwuX4 It’s common knowledge that your computer can be hacked, but are you aware of the bevy of devices, items and industries that are also at risk of attack? In this new world of the Internet of Things, everyday life is made easier, but also more vulnerable. Here are 14 things you probably didn’t know could be hacked.
